-transparent.png){kind=logo}
In the F1 hybrid of autoimmune New Zealand Black (NZB) and phenotypically normal New Zealand White (NZW) mice, there occurs a severe systemic lupus erythematosus (SLE)-like autoimmune disease more fulminant than that found in the parental NZB mice. To determine the role of the H-2 complex in the pathogenesis of autoimmune disease of the (NZB X NZW)F1 hybrid, we developed H-2-congenic NZB (NZB.H-2z) and NZW (NZW.H-2d) strains, and compared the degree of autoimmune features between congenic H-2d/H-2d and H-2z/H-2z homozygous F1 hybrids and the original H-2d/H-2z heterozygous (NZB X NZW)F1 hybrid. We found that autoimmune features such as productions of IgG class anti-DNA antibodies and retroviral gp70 immune complexes and the development of renal disease were to a great extent reduced in both H-2 homozygous F1 hybrids, as compared with the H-2 heterozygous (NZB X NZW)F1 hybrid. It would thus appear that the heterozygosity of H-2d haplotype derived from NZB and H-2z from NZW is essential for the autoimmune disease characteristic of the (NZB X NZW)F1 hybrid.
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
March 2005,
Environmental health perspectives,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
June 1979,
European journal of immunology,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
March 1968,
Lancet (London, England),
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
January 2009,
Lupus,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
November 1994,
Physiology & behavior,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
December 1979,
Arthritis and rheumatism,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
July 1983,
The Journal of experimental medicine,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
January 1978,
Journal of immunopharmacology,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
April 1970,
Nature,
S Hirose, and
G Ueda, and
K Noguchi, and
T Okada, and
I Sekigawa, and
H Sato, and
T Shirai
January 1987,
Clinical immunology and immunopathology,
